Literature DB >> 21844234

Interleukin-1 receptor-associated kinase 4 is essential for initial host control of Brucella abortus infection.

Fernanda S Oliveira1, Natália B Carvalho, Ana Paula M S Brandão, Marco Túlio R Gomes, Leonardo A de Almeida, Sérgio C Oliveira.   

Abstract

Brucella abortus is a facultative intracellular bacterial pathogen that causes abortion in domestic animals and undulant fever in humans. Recent studies have revealed that Toll-like receptor (TLR)-initiated immune response to Brucella spp. depends on myeloid differentiation factor 88 (MyD88) signaling. Therefore, we decided to study the role of the interleukin-1 receptor-associated kinase 4 (IRAK-4) in host innate immune response against B. abortus. After Brucella infection, it was shown that the number of CFU in IRAK-4(-/-) mice was high compared to that in IRAK-4(+/-) animals only at 1 week postinfection. At 3 and 6 weeks postinfection, IRAK-4(-/-) mice were able to control the infection similarly to heterozygous animals. Furthermore, the type 1 cytokine profile was evaluated. IRAK-4(-/-) mice showed lower production of systemic interleukin-12 (IL-12) and gamma interferon (IFN-γ). Additionally, a reduced percentage of CD4(+) and CD8(+) T cells expressing IFN-γ was observed compared to IRAK-4(+/-). Further, the production of IL-12 and tumor necrosis factor alpha (TNF-α) by macrophages and dendritic cells from IRAK-4(-/-) mice was abolished at 24 h after stimulation with B. abortus. To investigate the role of IRAK-4 in mitogen-activated protein kinase (MAPK) and NF-κB signaling pathways, macrophages were stimulated with B. abortus, and the signaling components were analyzed by protein phosphorylation. Extracellular signal-regulated kinase 1 (ERK1) and ERK2 and p38 as well as p65 NF-κB phosphorylation was profoundly impaired in IRAK-4(-/-) and MyD88(-/-) macrophages activated by Brucella. In summary, the results shown in this study demonstrated that IRAK-4 is critical to trigger the initial immune response against B. abortus but not at later phases of infection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21844234      PMCID: PMC3257947          DOI: 10.1128/IAI.05289-11

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

1.  Penetration and intracellular growth of Brucella abortus in nonphagocytic cells in vitro.

Authors:  P G Detilleux; B L Deyoe; N F Cheville
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

2.  IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling.

Authors:  M Muzio; J Ni; P Feng; V M Dixit
Journal:  Science       Date:  1997-11-28       Impact factor: 47.728

3.  IRAK-M is a novel member of the Pelle/interleukin-1 receptor-associated kinase (IRAK) family.

Authors:  H Wesche; X Gao; X Li; C J Kirschning; G R Stark; Z Cao
Journal:  J Biol Chem       Date:  1999-07-02       Impact factor: 5.157

4.  Endogenous gamma interferon mediates resistance to Brucella abortus infection.

Authors:  Y Zhan; C Cheers
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

Review 5.  Brucellosis: an overview.

Authors:  M J Corbel
Journal:  Emerg Infect Dis       Date:  1997 Apr-Jun       Impact factor: 6.883

6.  The role of T cell subsets and cytokines in the regulation of intracellular bacterial infection.

Authors:  S C Oliveira; J S Harms; E L Rech; R S Rodarte; A L Bocca; A M Goes; G A Splitter
Journal:  Braz J Med Biol Res       Date:  1998-01       Impact factor: 2.590

7.  IRAK: a kinase associated with the interleukin-1 receptor.

Authors:  Z Cao; W J Henzel; X Gao
Journal:  Science       Date:  1996-02-23       Impact factor: 47.728

8.  CD8+ type 1 CD44hi CD45 RBlo T lymphocytes control intracellular Brucella abortus infection as demonstrated in major histocompatibility complex class I- and class II-deficient mice.

Authors:  S C Oliveira; G A Splitter
Journal:  Eur J Immunol       Date:  1995-09       Impact factor: 5.532

9.  The role of interleukin 1 receptor-associated kinase-4 (IRAK-4) kinase activity in IRAK-4-mediated signaling.

Authors:  Elizabeth Lye; Christine Mirtsos; Nobutaka Suzuki; Shinobu Suzuki; Wen-Chen Yeh
Journal:  J Biol Chem       Date:  2004-07-29       Impact factor: 5.157

10.  Defective interleukin (IL)-18-mediated natural killer and T helper cell type 1 responses in IL-1 receptor-associated kinase (IRAK)-deficient mice.

Authors:  P Kanakaraj; K Ngo; Y Wu; A Angulo; P Ghazal; C A Harris; J J Siekierka; P A Peterson; W P Fung-Leung
Journal:  J Exp Med       Date:  1999-04-05       Impact factor: 14.307

View more
  16 in total

1.  TLR2 and TLR4 signaling pathways are required for recombinant Brucella abortus BCSP31-induced cytokine production, functional upregulation of mouse macrophages, and the Th1 immune response in vivo and in vitro.

Authors:  Jia-Yun Li; Yuan Liu; Xiao-Xue Gao; Xiang Gao; Hong Cai
Journal:  Cell Mol Immunol       Date:  2014-04-28       Impact factor: 11.530

2.  Impaired innate immunity in mice deficient in interleukin-1 receptor-associated kinase 4 leads to defective type 1 T cell responses, B cell expansion, and enhanced susceptibility to infection with Toxoplasma gondii.

Authors:  Samantha R Béla; Míriam S Dutra; Ernest Mui; Alexandre Montpetit; Fernanda S Oliveira; Sérgio C Oliveira; Rosa M E Arantes; Lis R Antonelli; Rima McLeod; Ricardo T Gazzinelli
Journal:  Infect Immun       Date:  2012-10-01       Impact factor: 3.441

3.  IFN-γ-deficient mice develop IL-1-dependent cutaneous and musculoskeletal inflammation during experimental brucellosis.

Authors:  Jerod A Skyberg; Theresa Thornburg; Irina Kochetkova; William Layton; Gayle Callis; MaryClare F Rollins; Carol Riccardi; Todd Becker; Sarah Golden; David W Pascual
Journal:  J Leukoc Biol       Date:  2012-05-25       Impact factor: 4.962

4.  Immunoproteasome Subunits Are Required for CD8+ T Cell Function and Host Resistance to Brucella abortus Infection in Mice.

Authors:  Gabriela Guimarães; Marco Túlio R Gomes; Priscila C Campos; Fabio V Marinho; Natan R G de Assis; Tatiana N Silveira; Sergio C Oliveira
Journal:  Infect Immun       Date:  2018-02-20       Impact factor: 3.441

5.  TLR9 is required for MAPK/NF-κB activation but does not cooperate with TLR2 or TLR6 to induce host resistance to Brucella abortus.

Authors:  Marco Túlio Gomes; Priscila Carneiro Campos; Guilherme de Sousa Pereira; Daniella Castanheira Bartholomeu; Gary Splitter; Sergio Costa Oliveira
Journal:  J Leukoc Biol       Date:  2015-11-17       Impact factor: 4.962

6.  Complete dependence on IRAK4 kinase activity in TLR2, but not TLR4, signaling pathways underlies decreased cytokine production and increased susceptibility to Streptococcus pneumoniae infection in IRAK4 kinase-inactive mice.

Authors:  Meghan E Pennini; Darren J Perkins; Andres M Salazar; Michael Lipsky; Stefanie N Vogel
Journal:  J Immunol       Date:  2012-12-03       Impact factor: 5.422

7.  Toll-like receptor 6 plays an important role in host innate resistance to Brucella abortus infection in mice.

Authors:  Leonardo A de Almeida; Gilson C Macedo; Fábio A V Marinho; Marco T R Gomes; Patrícia P Corsetti; Aristóbolo M Silva; Juliana Cassataro; Guillermo H Giambartolomei; Sergio C Oliveira
Journal:  Infect Immun       Date:  2013-03-04       Impact factor: 3.441

Review 8.  What have we learned from brucellosis in the mouse model?

Authors:  María-Jesús Grilló; José María Blasco; Jean Pierre Gorvel; Ignacio Moriyón; Edgardo Moreno
Journal:  Vet Res       Date:  2012-04-13       Impact factor: 3.683

9.  Toll-like receptors are critical for clearance of Brucella and play different roles in development of adaptive immunity following aerosol challenge in mice.

Authors:  Jianwu Pei; Xicheng Ding; Yaping Fan; Allison Rice-Ficht; Thomas A Ficht
Journal:  Front Cell Infect Microbiol       Date:  2012-09-07       Impact factor: 5.293

Review 10.  The role of innate immune signals in immunity to Brucella abortus.

Authors:  Marco Túlio R Gomes; Priscila C Campos; Leonardo A de Almeida; Fernanda S Oliveira; Miriam Maria S Costa; Fernanda M Marim; Guilherme S M Pereira; Sergio C Oliveira
Journal:  Front Cell Infect Microbiol       Date:  2012-10-25       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.